Alyeska Investment Group
NFH.WS

Alyeska Investment Group’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Alyeska Investment Group’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-237,737
Closed -$1.97M – 633
2020
Q2 		$1.97M Sell
237,737
-62,263
-21% -$77.7K 0.03% 357
2020
Q1 		$2.48M Buy
+300,000
New +$370K 0.05% 246

Other funds holding NFH.WS

BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MAM
Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Alyeska Investment Group's NFH.WS Position: Q3 2020 in Review

Alyeska Investment Group sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q3 2020, closing a stake of 237,737 shares — an estimated $1.97M sold.

Alyeska Investment Group first reported a position in NFH.WS in Q1 2020 and held it in 2 quarters. The position peaked at $2.48M in Q1 2020. 16 funds tracked by Wall St. Rank hold NFH.WS as of Q3 2020.

  • Alyeska Investment Group reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q3 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 237,737 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q3 2020, an estimated $1.97M.
  • Alyeska Investment Group first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q1 2020 and held it in 2 quarters.
  • Alyeska Investment Group's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $2.48M in Q1 2020.
  • 16 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q3 2020.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.